The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways
Open accessAbstract
Interleukin-10 (IL-10) limits inflammatory responses by inhibiting macrophage activation. In macrophages, IL-10 activates Stat1 and Stat3. We characterized IL-10 responses of the J774 mouse macrophage cell line, and of J774 cells expressing wild-type hIL-10R, mutant hIL-10R lacking two membrane-distal tyrosines involved in recruitment of Stat3 (hIL-10R-TyrFF), a truncated Stat3 (DeltaStat3) which acts as a dominant negative, or an inducibly active Stat3-gyraseB chimera (Stat3-GyrB). A neutralizing anti-mIL-10R monoclonal antibody was generated to block the function of endogenous mIL-10R. IL-10 inhibited proliferation of J774 cells and of normal bone marrow-derived macrophages, but not J774 cells expressing hIL-10RTyrFF. Dimerization of Stat3-GyrB by coumermycin mimicked the effect of IL-10, and expression of DeltaStat3 blocked the anti-proliferative activity of IL-10. For macrophage de-activation responses, hIL10R-TyrFF could not mediate inhibition of lipopolysaccharide-induced TNFalpha, IL-1beta or CD86 expression, while DeltaStat3 did not interfere detectably with these IL-10 responses. Thus signals mediating both anti-proliferative and macrophage de-activation responses to IL-10 require the two membrane-distal tyrosines of IL-10R, but Stat3 appears to function only in the anti-proliferative response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Ding, A. H., Nathan, C. F., & Stuehr, D. J. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2407 · Cited by 2,826
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070 · cited 1×
“IL-6, a cytokine which signals via gp130 and activates Stat3 (Zhong et al., 1994), promotes growth arrest, differentiation and apoptosis of the M1 cell line.”
BackgroundWen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Moore, K. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.165 · Cited by 1,884
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., & Akira, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3801 · Cited by 1,323 · cited 1×
“Embryonic lethality in mice homozygous for targeted disruption of the Stat3 gene (Takede et al., 1997) precludes similar analysis of IL-10 responses.”
ResultInterleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., & Banchereau, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1890 · Cited by 1,238
Vieira, P., de Waal-Malefyt, R., Dang, M. N., Johnson, K. E., Kastelein, R., Fiorentino, D. F., deVries, J. E., Roncarolo, M. G., Mosmann, T. R., & Moore, K. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1172 · Cited by 739
A Common Nuclear Signal Transduction Pathway Activated by Growth Factor and Cytokine Receptors
Sadowski, H. B., Shuai, K., Darnell, J. E., & Gilman, M. Z. (1993) · Science · doi:10.1126/science.8397445 · Cited by 699
Chin, Y. E., Kitagawa, M., Su, W.-C. S., You, Z.-H., Iwamoto, Y., & Fu, X.-Y. (1996) · Science · doi:10.1126/science.272.5262.719 · Cited by 696
Functional interactions between Stat5 and the glucocorticoid receptor
Stöcklin, E., Wissler, M., Gouilleux, F., & Groner, B. (1996) · Nature · doi:10.1038/383726a0 · Cited by 675
Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K., & Hirano, T. (1996) · Immunity · doi:10.1016/s1074-7613(00)80501-4 · Cited by 652
de Waal Malefyt, R., Yssel, H., & de Vries, J. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.11.4754 · Cited by 603
Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M., & Hirano, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00734.x · Cited by 565
Interleukin 10: a novel stimulatory factor for mast cells and their progenitors.
Thompson-Snipes, L., Dhar, V, Bond, M. W., Mosmann, T. R., Moore, K. W., & Rennick, D. M. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.2.507 · Cited by 495
Mui, A. L., Wakao, H., O'Farrell, A. M., Harada, N., & Miyajima, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07100.x · Cited by 493
Self-citationCooperation of Stat2 and p300/CBP in signalling induced by interferon-α
Bhattacharya, S., Eckner, R., Grossman, S., Oldread, E., Arany, Z., D'Andrea, A., & Livingston, D. M. (1996) · Nature · doi:10.1038/383344a0 · Cited by 493
Two contact regions between Stat1 and CBP/p300 in interferon γ signaling
Zhang, J. J., Vinkemeier, U., Gu, W., Chakravarti, D., Horvath, C. M., & Darnell, J. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15092 · Cited by 483
IL-10 inhibits human T cell proliferation and IL-2 production
Taga, K., & Tosato, G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1143 · Cited by 482
Go, N. F., Castle, B. E., Barrett, R., Kastelein, R., Dang, W., Mosmann, T. R., Moore, K. W., & Howard, M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1625 · Cited by 475
Bromberg, J. F., Horvath, C. M., Wen, Z., Schreiber, R. D., & Darnell, J. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7673 · Cited by 422
Finbloom, D. S., & Winestock, K. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1079 · Cited by 421
Chernoff, A. E., Granowitz, E. V., Shapiro, L., Vannier, E., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Wolff, S. M., & Dinarello, C. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5492 · Cited by 418
Regulation of Interferon-γ-Activated STAT1 by the Ubiquitin-Proteasome Pathway
Kim, T. K., & Maniatis, T. (1996) · Science · doi:10.1126/science.273.5282.1717 · Cited by 401
IL-10, a novel growth cofactor for mature and immature T cells.
MacNeil, I. A., Suda, T., Moore, K. W., Mosmann, T. R., & Zlotnik, A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4167 · Cited by 360
Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3.
Schaefer, T. S., Sanders, L. K., & Nathans, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9097 · Cited by 357
Minami, M., Inoue, M., Wei, S., Takeda, K., Matsumoto, M., Kishimoto, T., & Akira, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3963 · Cited by 335
Mui, A. L., Wakao, H., Kinoshita, T., Kitamura, T., & Miyajima, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00600.x · Cited by 330
Applications of retrovirus-mediated expression cloning.
Onishi, M., Kinoshita, S. M., Morikawa, Y., Shibuya, A., Phillips, J. H., Lanier, L. L., Gorman, D. M., Nolan, G. P., Miyajima, A., & Kitamura, T. (1996) · PubMed · Cited by 329
Expression cloning and characterization of a human IL-10 receptor.
Liu, Y., Wei, S. H., Ho, A. S. Y., de Waal Malefyt, R., & Moore, K. W. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.1821 · Cited by 321
Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization
Farrar, M. A., Alberola-lla, J., & Perlmutter, R. M. (1996) · Nature · doi:10.1038/383178a0 · Cited by 318
Haspel, R. L., Salditt‐Georgieff, M., & Darnell, J. E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01016.x · Cited by 312 · cited 1×
“Stat proteins can be modified by Ser/Thr phosphorylation, ubiquitination and phosphatase activity (Wen et al., 1995; Haspel et al., 1996; Kim and Maniatis, 1996; Sasse et al., 1997).”
BackgroundStat1 Depends on Transcriptional Synergy with Sp1
Look, D. C., Pelletier, M. R., Tidwell, R. M., Roswit, W. T., & Holtzman, M. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30264 · Cited by 268
Efficient screening of retroviral cDNA expression libraries.
Kitamura, T., Onishi, M., Kinoshita, S., Shibuya, A., Miyajima, A., & Nolan, G. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9146 · Cited by 241
Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses.
Berg, D. J., Leach, M. W., Kühn, R., Rajewsky, K., Müller, W., Davidson, N. J., & Rennick, D. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.99 · Cited by 239
A receptor for interleukin 10 is related to interferon receptors.
Ho, A. S., Liu, Y., Khan, T. A., Hsu, D. H., Bazan, J. F., & Moore, K. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11267 · Cited by 230
Weber-Nordt, R. M., Riley, J. K., Greenlund, A. C., Moore, K. W., Darnell, J. E., & Schreiber, R. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27954 · Cited by 218
te Velde, A. A., de Waal Malefijt, R., Huijbens, R. J., de Vries, J. E., & Figdor, C. G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.12.4048 · Cited by 217
Ludewig, B., Graf, D., Gelderblom, H. R., Becker, Y., Kroczek, R. A., & Pauli, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250722 · Cited by 211
Wehinger, J., Gouilleux, F., Groner, B., Finke, J., Mertelsmann, R., & Maria Weber-Nordt, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00990-8 · Cited by 167
The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor
Liu, Y., de Waal Malefyt, R., Briere, F., Parham, C., Bridon, J. M., Banchereau, J., Moore, K. W., & Xu, J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.604 · Cited by 166
The Interaction of Coumarin Antibiotics with Fragments of the DNA Gyrase B Protein
Gormley, N. A., Orphanides, G., Meyer, A., Cullis, P. M., & Maxwell, A. (1996) · Biochemistry · doi:10.1021/bi952888n · Cited by 163
Shuai, K., Liao, J., & Song, M. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4932 · Cited by 158
Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells.
Fluckiger, A., Durand, I., & Banchereau, J. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.1.91 · Cited by 151
Mutational analysis of acute-phase response factor/Stat3 activation and dimerization
Sasse, J., Hemmann, U., Schwartz, C., Schniertshauer, U., Heesel, B., Landgraf, C., Schneider-Mergener, J., Heinrich, P. C., & Horn, F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4677 · Cited by 120
IL-10 inhibits apoptotic cell death in human T cells starved of IL-2
Taga, K., Cherney, B., & Tosato, G. (1993) · International Immunology · doi:10.1093/intimm/5.12.1599 · Cited by 119
Interleukin-10 gene knock-out mice: a model of chronic inflammation
Rennick, D. M., Davidson, N. J., & Berg, D. (1995) · Clinical Immunology and Immunopathology · doi:10.1016/s0090-1229(95)90144-2 · Cited by 117
Functional Regions of the Mouse Interleukin-10 Receptor Cytoplasmic Domain
Ho, A. S.-Y., Wei, S. H.-Y., Mui, A., Miyajima, A., & Moore, K. W. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.5043 · Cited by 116
Fujihara, M., Ito, N., Pace, J. L., Watanabe, Y., Russell, S. W., & Suzuki, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99942-4 · Cited by 106
Lai, C., Ripperger, J. A., Morella, K. K., Jurlander, J., Hawley, T. S., Carson, W. E., Kordula, T., Caligiuri, M. A., Hawley, R. G., Fey, G. H., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.13968 · Cited by 101
Interleukin-10 and its receptor.
Ho, A. S., & Moore, K. W. (1994) · PubMed · Cited by 100
Clinical, hematologic, and immunologic effects of interleukin-10 in humans
Fuchs, A. C., Granowitz, E. V., Shapiro, L., Vannier, E. G., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Radwanski, E., Affrime, M. B., et al. (1996) · Journal of Clinical Immunology · doi:10.1007/bf01541395 · Cited by 90
Weber-Nordt, R., Henschler, R., SchOTT, E. H., Wehinger, J., Behringer, D. M., Mertelsmann, R. H., & Finke, J. (1996) · Blood · doi:10.1182/blood.v88.7.2549.bloodjournal8872549 · Cited by 81
O'Farrell, A.-M., Ichihara, M., Mui, A. L.-F., et al. (1996) · Blood · doi:10.1182/blood.v87.9.3655.bloodjournal8793655 · Cited by 64
Self-citationEffects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia.
Bruserud, Ø., Gjertsen, B. T., Ot, B., Bassøe, C., Nesthus, I., Espen Akselsen, P., Bühring, H. ‐., & Pawelec, G. (1995) · PubMed · Cited by 64
Geissler, K. H., Öhler, L., Födinger, M., Virgolini, I. J., Leimer, M., Kabrna, E., Kollars, M., Skoupy, S., Bohle, B., Rogy, M. A., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.4.1377 · Cited by 62
Kordula, T., & Travis, J. W. (1996) · Biochemical Journal · doi:10.1042/bj3131019 · Cited by 55
Oehler, L., Föedinger, M., Koeller, M., Kollars, M., Reiter, E., Bohle, B., Skoupy, S., Fritsch, G., Lechner, K., & Geissler, K. H. (1997) · Blood · doi:10.1182/blood.v89.4.1147 · Cited by 53
Interleukin-2 (IL-2)-mediated Induction of the IL-2 Receptor α Chain Gene
Ascherman, D. P., Migone, T., Friedmann, M. C., & Leonard, W. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8704 · Cited by 38
Finbloom, D. S., Larner, A. C., Nakagawa, Y., & Hoover, D. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.6.2383 · Cited by 33
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Self-citationMolecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
Wang, N., Liang, H., & Zen, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00614 · Cited by 1,980
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M., & Sacks, D. L. (2002) · Nature · doi:10.1038/nature01152 · Cited by 1,725
Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., & Powrie, F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.995 · Cited by 1,615
Metadata
- Authors
- O'Farrell, A.-M.
- Venue
- The EMBO Journal
- Published
- 1998-02-15
- Volume
- 17
- Issue
- 4
- Pages
- 1006-1018
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W1977979649
- Cited by
- 439
- References
- 63
- FWCI
- 9.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.